Please type a search term (at least two characters)
Innovative MRI-guided radiotherapy method rolled out for clinical use in EMPIR project - first patients treated in May 2017
Radiotherapy is a powerful tool in modern cancer treatment – around 40 % of people who survive cancer do so because of radiotherapy. MRI-guided radiotherapy can further improve the success of cancer treatments by offering better targeted therapy through real-time imaging. Demonstrating that radiotherapy works in the presence of MRI magnetic fields and the radiation dose delivered to patients can be accurately and consistently determined are essential before it can be introduced into clinics.
The feasibility of calibrating clinical MRI-guided radiotherapy machines was successfully demonstrated in the EMRP project Metrology for next-generation safety standards and equipment in MRI (HLT06 MRI safety). This has been further developed to support clinical implementation in the EMPIR project Metrology for MR guided radiotherapy (15HLT08 MRgRT). Results from the project have demonstrated that MRI-guided radiotherapy can be reliably linked to the traditional radiotherapy beam calibration method based on water calorimetry measurements to which clinics have existing traceability. This essential development has enabled Elekta, a leading European manufacturer of radiotherapy machines and academic hospitals, to rollout innovative MRI-guided radiotherapy for clinical use. The first patients to benefit from this new method were treated in May 2017.
An award winning EMPIR project in the field of small current measurements is making impact in many diverse areas more
Project consortium organises session on atmospheric gases and particles more
EMPIR project consortium work together to transfer expertise to enable the establishment of a new centre of excellence more
Participant discussions provide valuable input for the working group, helping it to better support EURAMET with the digital transformation of European... more
Cardiovascular diseases are the leading cause of death globally, but an EMPIR project has provided a new tool to fight these disorders more